The Fly

Bio-Techne price target adjusted to $105 for stock split at Stephens

Stephens analyst Jacob Johnson adjusted the firm’s price target on Bio-Techne to $105 from $420 following a 4-for-1 stock split that took effect this week and keeps an Overweight rating on the shares. There are no changes to his FY23 and FY24 revenue estimates for Bio-Techne, Johnson noted.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on TECH:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More